Search

everythinglearnresearchcommunity

for

Search:↓

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

The document suggests a bacteria plays a significant role in acne rosacea and that white hair can regain color after transplant, meriting more research on reversing grey hair.

Mast cells and VEGF contribute to post-surgery adhesions, and blocking VEGF can reduce these adhesions; also, certain factors affect wound healing and fetal skin heals differently with age.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Itch is a common symptom in patients with chronic venous insufficiency, often accompanied by burning and pain.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Itch is a common symptom in patients with chronic venous insufficiency, often worsening with standing or sitting and occurring mostly in the evening or at night.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

The exam tested knowledge on various skin-related topics for CME credit.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

A new protein linked to Alzheimer's was discovered, and a hair loss treatment showed effectiveness but had some sexual side effects.

Finasteride increased hair count and regrowth in men with hair loss but also caused more sexual side effects than placebo.

Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.

Certain maturity signs appear before and after the first release of sperm in boys.

A document listed serious side effects from various drugs, including deaths and diseases, emphasizing the importance of being aware of drug side effects.

Hair growth can be induced by transplanting certain cells, but these cells lose their properties during culturing. The best cell interaction happens in a liquid medium under gravity, and using collagen doesn't help. Future research could focus on using growth factors to stimulate these cells.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Auto-portraits help evaluate scalp hair.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Minoxidil helps hair growth by activating enzymes in hair follicles.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Oral cyclosporin doesn't stop hair loss.